Poland· PL-100025669
Garamycin
A gentamicin product containing gentamicini sulfas, registered in Poland by SERB S.A.. The same ATC class is registered in 15 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Gentamicin is registered in 15 of 19 countries.
Countries holding a registration under ATC J01GB03 (gentamicin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Gentamicin · ATC J01GB03
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of gentamicin costs, country by country.
Normalised to the WHO defined daily dose (0.24 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Gentamicin · price per daily dose (0.24 g)
USD · FX 28 Sept 2026
- CH Switzerland$578.87
The record
At a glance
URPL (Poland)- Active substance
- Gentamicini sulfas
- Manufacturer
- SERB S.A.
- Country
- Poland (PL)
- ATC code
- J01GB03
- ATC class
- Gentamicin
- Defined daily dose
- 0.24 g, P
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 6
- gtin05909990322213
- gtin05909990322237
- gtin05909990322220
- gtin05055956400393
- gtin05055956400409
- gtin05055956400416
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
338 interactions on record for gentamicin.
Graded by severity as the source publishes them — 51 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Gentamicin · interactions on record
338 records
- 51 severe
- 126 moderate
- 4 minor
- 157 info
Most severe, free to view
- Magnesium sulfateA06AD04severe
- MannitolA06AD16severe
- Polymyxin BA07AA05severe
- Magnesium sulfateA12CC02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Gentamicin in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesGentakProficient Rx LP
- United KingdomCMW 1 Gentamicin cement 20g sachetsDepuy International Ltd
- CzechiaGARAMYCIN SCHWAMMSERB S.A., Brusel
- FinlandGensumycinOrifarm Oy
- GermanyGent-OphtalDr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh
- BelgiumDexagenta-Pos 1 mg/ml - 5 mg/mlURSAPHARM Benelux
- NorwayGent-OphtalDr. Gerhard Mann
- IrelandGenticin 0.3% w/v Eye/Ear Drops, SolutionAmdipharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 17 EEA countries. Names it is sold under:
- Austria · Gentax, Refobacin
- Bulgaria · Гентамицин Актавис, Гентамицин Софарма
- Czechia · Gentamicin Polpharma
- Germany · Gent-Ophtal, Gent-Ophtal®
- Denmark · Gentamicin Panpharma
- Estonia · Gentamicin Medochemie
- United Kingdom (Northern Ireland) · Gentamicin Amdipharm Uk, Gentamicin Intrathecal Zentiva Pharma Uk Limited
- Hungary · Gentamicin Wagner
- Ireland · Gentamicin Pinewood Laboratories, Genticin
- Italy · Ciclozinil, Gentalyn
- Lithuania · Gentamicin Pph
- Malta · Gentamicin Medochemie
- Netherlands · Garacol, Gentamicine-Pos
- Norway · Gentamicin Panpharma
- Portugal · Cronocol, Gentamicina Basi
- Sweden · Gentamicin Panpharma
- Slovakia · Garamycin Schwamm
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ad349abc-2edc-4b3c-b182-517080d87e1e GET /v1/drugs/ad349abc-2edc-4b3c-b182-517080d87e1e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Gąbka",
"source": "urpl",
"strength": "2 mg/cm2",
"packaging": "Lz ¦ Skasowane ¦ 4134\n1 szt. 10x10x0,5 cm\nLz ¦ Skasowane ¦ 4135\n5 szt. 10x10x0,5 cm\nLz ¦ Skasowane ¦ 4136\n10 szt. 10x10x0,5 cm\n05909990322213 ¦ Rp ¦ Skasowane ¦ 13692\n1 szt.\n05909990322237 ¦ Rp ¦ 13694\n10 szt.\n05909990322220 ¦ Rp ¦ 65802\n5 szt.\nRp ¦ Skasowane ¦ 65875\n1 szt.\n05055956400393 ¦ Rp ¦ 133873\n1 szt.\n05055956400409 ¦ Rp ¦ 133874\n1 szt.\n05055956400416 ¦ Rp ¦ 133875\n1 szt.",
"substance": "Gentamicinum 130 mg",
"common_name": "Gentamicini sulfas",
"pl_product_id": "100025669",
"pozwolenie_nr": "03222",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about gentamicin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.